Tom Payne joined the Gates Center for Regenerative Medicine and Stem Cell Biology in the fall of 2012 to lead the planning and start-up of the Gates Biomanufacturing Facility, which will be located across the street from the Anschutz Medical Campus. This facility will be designed and operated to support the manufacture of cell and tissue-based products as well as biotechnology-derived therapeutics for phase 1 and 2 clinical trials. Growing up near Chicago, Tom received his Bachelor of Science degree in molecular biology and mathematics from Benedictine University in Lisle, IL. He later received his Ph.D. in Bioengineering at the University of Pittsburgh where he was exposed to the exciting field of regenerative medicine and performed research investigating cell and gene therapy for the treatment of heart failure, which he continued at Cook MyoSite Inc., a biotechnology company in Pittsburgh. During Tom’s six years at Cook MyoSite, he was also involved in the start-up of a new manufacturing facility to process autologous stem cells for use in various human clinical trials of cell therapy, including treatments for urinary incontinence and heart failure.